Michael Breen
Executive Chairman, Board of Directors, Chief Executive Officer
Michael Breen is an English qualified solicitor/attorney and was formerly the Managing Director of the Sports and Entertainment Division of Bank Insinger de Beaufort N. V., which is a wealth management organization and was part of BNP Paribas Group, one of the world's largest banks. The holding company Insinger de Beaufort Holdings S.A. was listed on the Luxembourg Stock Exchange. Mr. Breen was also a director and major shareholder of an affiliate of Insinger de Beaufort Holdings S.A.
Mr. Breen is a former senior equity partner in the 400+ partner and 50+ office law firm of Clyde & Co, whose head office is based in the City of London, England.
Charles J. Casamento
Independent Director
Mr. Casamento is currently executive director and principal of The Sage Group, a healthcare advisory group specializing in mergers, acquisitions, and partnerships between biotechnology companies and pharmaceutical companies, since 2007. Mr. Casamento’s career in healthcare spans more than 35 years, where he was a founder or had held senior management roles at various biopharmaceutical companies including Osteologix Inc., Questcor Pharmaceuticals, Inc., RiboGene, Inc., Interneuron Pharmaceuticals (Indevus), Genzyme Corporation, amongst other companies.
Mr. Casamento also serves on the board of directors of the following NASDAQ listed companies: Eton Pharmaceuticals, Inc., First Wave Biopharma, Inc., PaxMedica, Inc., and Relmada Therapeutics, Inc. During his career he has served on the boards of fourteen Biotech/Pharma companies and has also been a director and vice chairman of The Catholic Medical Missions Board, a large not-for-profit organization providing health care services to third world countries. He has served as a guest lecturer at Fordham University and is on the Science Council of Fordham University.
He holds a bachelor’s degree in Pharmacy from Fordham University and an MBA from Iona University and was originally licensed to practice pharmacy in the states of New York and New Jersey. Mr. Casamento’s significant experience in the biotechnology sector make him a valuable addition to the Board.
Mr. Casamento chairs the company’s Audit Committee.
Hilary Kramer
Independent Director
Ms. Kramer is a former analyst and investment banker at Morgan Stanley and Lehman Brothers, founder of an institutional long-short hedge fund and has been chief investment officer managing more than $12 billion of debt and equity portfolios and private equity investments. Ms. Kramer has served on the boards of numerous publicly-traded companies and on the advisory boards of businesses including DirecTV International and Ibero-American Media Partners with Hicks Muse. Ms. Kramer serves as a consultant for family offices and institutions, such as Montgomery Asset Management, Freddie Mac, and families on the Forbes Global Billionaires list. Ms. Kramer is the President and Chief Investment Officer of GreenTech Research, the first cleantech hedge fund that also produces investment research and global market commentary. She is the author of Ahead of the Curve (Simon & Schuster 2007) and The Little Book of Big Profits from Small Stocks (Wiley 2012). Her book, Game Changing Investing (Regnery 2020) reached first place on the best-selling lists at “The Wall Street Journal”, “USA TODAY” and on Amazon.com. Ms. Kramer was a founding member of the "Wall Street Journal" Women in Business and is often a keynote speaker on the markets, global trends and has also testified on investing, accounting and financial matters before Senate Committees. Ms. Kramer is the 2021 winner of the Gracie Award for best weekend nationally syndicated talk show and is seen regularly as both a commentator and editorial opinion writer for Fox Business, Bloomberg, Forbes and CNBC. Ms. Kramer holds an MBA from the Wharton School of the University of Pennsylvania and a BA with honors from Wellesley College.
Ms. Kramer chairs the company’s Nominating & Corporate Governance Committee.
David C. Mun-Gavin
Independent Director
Mr. Mun-Gavin has decades of executive leadership experience at the very highest levels and has served as the Client Director, International Private Banking Division, of Brown Shipley, a Quintet private bank, since October, 2018. Prior to this, Mr. Mun-Gavin served in various roles at Insinger De Beaufort, Credit Suisse, The Vanol Group, Swiss Bank Corporation Investment Banking Ltd., Bankers Trust International Limited, the Dr. Jonathan Beare Family Office, and Goldby, Compton and Mackelvie Durban. Mr. Mun-Gavin earned a certificate in the theory of accountancy at University of Natal.
Mr. Mun-Gavin chairs the Company’s Compensation Committee.